Vysribli

denosumab · Intas Third Party Sales 2005 S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vysribli, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: EMA Authorised: Vysribli (previously Denosumab Intas) (denosumab) — Intas Third Party Sales 2005 S.L.